Patents Assigned to FERRUMAX CORPORATION
  • Patent number: 10273273
    Abstract: The present invention relates to hemojuvelin-IgG Fc domain fusion proteins, variants, derivatives, fragments and peptide mimetics derived therefrom and methods of using these fusion proteins for the regulation of iron homeostasis and the treatment of diseases related to iron homeostasis.
    Type: Grant
    Filed: July 17, 2017
    Date of Patent: April 30, 2019
    Assignees: THE GENERAL HOSPITAL CORPORATION, FERRUMAX CORPORATION
    Inventors: Herbert Y. Lin, Jodie L. Babitt, Tracey Menhall, Patrick Gearing
  • Patent number: 9708379
    Abstract: The present disclosure relates to hemojuvelin-IgG Fc domain fusion proteins, variants, derivatives, fragments and peptide mimetics derived therefrom and methods of using these fusion proteins for the regulation of iron homeostasis and the treatment of diseases related to iron homeostasis.
    Type: Grant
    Filed: January 19, 2012
    Date of Patent: July 18, 2017
    Assignees: THE GENERAL HOSPITAL CORPORATION, FERRUMAX CORPORATION
    Inventors: Herbert Y. Lin, Jodie L. Babitt, Tracey Menhall, Patrick Gearing